Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized, Double-blind, Parallel-controlled Versus Placebo in a Polyvalent Sublingual Bacterial Vaccine to 3 Months and 6 Months in Women With RUTI for the Immunomodulatory Efficacy Evaluation, Safety and Clinical Impact

NCT02543827 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT02543827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02543827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized, Double-blind, Parallel-controlled Versus Placebo in a Polyvalent Sublingual Bacterial Vaccine to 3 Months and 6 Months in Women With RUTI for the Immunomodulatory Efficacy Evaluation, Safety and Clinical Impact
Lead sponsor
Inmunotek S.L.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2015
Completion date
December 31, 2020
Enrollment
240 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

urinary tract infection bacterial